NSG552/NSG 552 EXAM 2
NSG 552 Psychopharmacology Exam 2 with (2
Version Exams) Questions and Answers with
Rationales, Verified For Learners - Wilkes
University
This Exam contains:
❖ (2 Exams)
❖ 100% Guarantee Pass.
❖ Multiple-Choice (A–D), For Each Question.
❖ Each Question Includes The Correct Answer
❖ Expert-Verified explanation
,Table of Contents
NSG552 / NSG 552 EXAM 2 VERSION 1............................. 1
NSG552 / NSG 552 EXAM 2 VERSION 2 .......................... 49
NSG552 / NSG 552 EXAM 2 VERSION 1
---
### 1. Why are benzodiazepines contraindicated in PTSD treatment?
Answer: Benzodiazepines are contraindicated because they interfere with cognitive
processes necessary for cognitive-behavioral therapy (CBT) and carry a high risk of
dependence, particularly in patients with comorbid substance use disorders (SUD).
Explanation: While benzodiazepines may provide short-term relief for anxiety, their
sedative effects can hinder emotional processing and cognitive functions critical for
recovery. This makes them unsuitable for PTSD treatment, where therapeutic
engagement is vital.
---
### 2. What medications are FDA-approved to treat PTSD?
Answer: Sertraline and paroxetine are the FDA-approved medications for treating
PTSD.
,Explanation: These SSRIs have undergone rigorous clinical testing demonstrating
their efficacy in relieving PTSD symptoms. Their approval indicates their importance in
treatment protocols, offering relief and improving quality of life for affected individuals.
---
### 3. When would you augment treatment of PTSD with an atypical antipsychotic?
Answer: Augmentation with an atypical antipsychotic is considered only in severe
cases of PTSD.
Explanation: Atypical antipsychotics may be effective in managing severe PTSD
symptoms, especially when first-line medications fail. However, they carry more
significant side effects and risks, so their use should be reserved for patients who have
not responded to SSRI treatment.
---
### 4. What co-occurring disorder do patients with DID typically have?
Answer: Patients with Dissociative Identity Disorder (DID) often have co-occurring
Post-Traumatic Stress Disorder (PTSD).
Explanation: The traumatic experiences that lead to DID frequently overlap with those
that cause PTSD. Both disorders can exacerbate each other, making integrated
treatment approaches essential for effective management.
### 5. What are adjustment disorders?
, Answer: Adjustment disorders occur when a person develops emotional or behavioral
symptoms in response to a stressful event or situation. Symptoms differ from normal
bereavement and typically resolve within 6 months after the stressor's end.
Explanation: Adjustment disorders highlight the challenge some individuals face in
adapting to stressors. Symptoms can include anxiety, sadness, and difficulty
functioning. Recognizing and intervening in adjustment disorders promptly can mitigate
the impact on a person's overall mental health and well-being.
---
### 6. Which class of medications are used as first-line therapy for PTSD?
Answer: Selective Serotonin Reuptake Inhibitors (SSRIs), specifically sertraline and
paroxetine, are the first-line pharmacological treatments for Post-Traumatic Stress
Disorder (PTSD).
Explanation: SSRIs work by increasing serotonin levels in the brain, which can
enhance mood and reduce symptoms of anxiety and depression often associated with
PTSD. Their efficacy and safety profile make them the preferred choice in clinical
guidelines.
---
### 7. What do you need to monitor if a patient is on Prazosin?
Answer: Blood pressure should be monitored in a patient taking Prazosin.
Explanation: Prazosin is an alpha-1 adrenergic antagonist prescribed for nightmares
related to PTSD. It can cause orthostatic hypotension, leading to dizziness and falls,
NSG 552 Psychopharmacology Exam 2 with (2
Version Exams) Questions and Answers with
Rationales, Verified For Learners - Wilkes
University
This Exam contains:
❖ (2 Exams)
❖ 100% Guarantee Pass.
❖ Multiple-Choice (A–D), For Each Question.
❖ Each Question Includes The Correct Answer
❖ Expert-Verified explanation
,Table of Contents
NSG552 / NSG 552 EXAM 2 VERSION 1............................. 1
NSG552 / NSG 552 EXAM 2 VERSION 2 .......................... 49
NSG552 / NSG 552 EXAM 2 VERSION 1
---
### 1. Why are benzodiazepines contraindicated in PTSD treatment?
Answer: Benzodiazepines are contraindicated because they interfere with cognitive
processes necessary for cognitive-behavioral therapy (CBT) and carry a high risk of
dependence, particularly in patients with comorbid substance use disorders (SUD).
Explanation: While benzodiazepines may provide short-term relief for anxiety, their
sedative effects can hinder emotional processing and cognitive functions critical for
recovery. This makes them unsuitable for PTSD treatment, where therapeutic
engagement is vital.
---
### 2. What medications are FDA-approved to treat PTSD?
Answer: Sertraline and paroxetine are the FDA-approved medications for treating
PTSD.
,Explanation: These SSRIs have undergone rigorous clinical testing demonstrating
their efficacy in relieving PTSD symptoms. Their approval indicates their importance in
treatment protocols, offering relief and improving quality of life for affected individuals.
---
### 3. When would you augment treatment of PTSD with an atypical antipsychotic?
Answer: Augmentation with an atypical antipsychotic is considered only in severe
cases of PTSD.
Explanation: Atypical antipsychotics may be effective in managing severe PTSD
symptoms, especially when first-line medications fail. However, they carry more
significant side effects and risks, so their use should be reserved for patients who have
not responded to SSRI treatment.
---
### 4. What co-occurring disorder do patients with DID typically have?
Answer: Patients with Dissociative Identity Disorder (DID) often have co-occurring
Post-Traumatic Stress Disorder (PTSD).
Explanation: The traumatic experiences that lead to DID frequently overlap with those
that cause PTSD. Both disorders can exacerbate each other, making integrated
treatment approaches essential for effective management.
### 5. What are adjustment disorders?
, Answer: Adjustment disorders occur when a person develops emotional or behavioral
symptoms in response to a stressful event or situation. Symptoms differ from normal
bereavement and typically resolve within 6 months after the stressor's end.
Explanation: Adjustment disorders highlight the challenge some individuals face in
adapting to stressors. Symptoms can include anxiety, sadness, and difficulty
functioning. Recognizing and intervening in adjustment disorders promptly can mitigate
the impact on a person's overall mental health and well-being.
---
### 6. Which class of medications are used as first-line therapy for PTSD?
Answer: Selective Serotonin Reuptake Inhibitors (SSRIs), specifically sertraline and
paroxetine, are the first-line pharmacological treatments for Post-Traumatic Stress
Disorder (PTSD).
Explanation: SSRIs work by increasing serotonin levels in the brain, which can
enhance mood and reduce symptoms of anxiety and depression often associated with
PTSD. Their efficacy and safety profile make them the preferred choice in clinical
guidelines.
---
### 7. What do you need to monitor if a patient is on Prazosin?
Answer: Blood pressure should be monitored in a patient taking Prazosin.
Explanation: Prazosin is an alpha-1 adrenergic antagonist prescribed for nightmares
related to PTSD. It can cause orthostatic hypotension, leading to dizziness and falls,
